Routine Peptide Mapping Analysis using the BioAccord System

Importance of the Topic

Peptide mapping at the protein level is a cornerstone technique for characterizing modifications of therapeutic proteins throughout their development lifecycle. Reliable identification and quantitation of sequence variants and post translational modifications ensure product quality and regulatory compliance. As biotherapeutic pipelines grow, laboratories require robust and user friendly platforms that streamline routine analyses without sacrificing data integrity.

Objectives and Study Overview

This work demonstrates how the BioAccord System with integrated analytical workflows simplifies routine peptide mapping applications. The goal is to showcase automated instrument setup, calibration, data acquisition, processing and reporting for consistent mapping of a monoclonal antibody standard.

Methodology

A tryptic digestion standard derived from a reference monoclonal antibody was analyzed using liquid chromatography coupled to mass spectrometry. The workflow employed alternating low and high energy scans to generate both intact peptide spectra and fragmentation data in a data independent acquisition mode. Automated sequence confirmation, post translational modification identification and relative quantitation were performed by a compliance ready informatics platform.

Instrumentation Used

• ACQUITY UPLC I Class PLUS System with optical detection (TUV or FLR)
• ACQUITY RDa Mass Detector operated in SmartMS mode
• UNIFI Scientific Information System for instrument control and data analysis

Main Results and Discussion

The workflow delivered greater than 95 percent sequence coverage for both light and heavy chains of the antibody standard at mass tolerance below 10 ppm. Consistent retention time profiles were observed across multiple injections. Key modifications were detected and quantified including N terminal pyroglutamic acid formation, C terminal lysine clipping, methionine oxidation and asparagine deamidation. The largest heavy chain peptide exhibited a well resolved monoisotopic peak and produced over 60 informative fragment ions for high confidence sequence verification.

Benefits and Practical Applications

The automated peptide mapping solution reduces instrument setup time and operator intervention through one click calibration and system readiness checks. Compliance ready reporting supports regulated environments while maintaining high throughput. This approach enables routine quality control of biopharmaceuticals in development and manufacturing laboratories.

Future Trends and Potential Applications

Advances may include expanded workflows for glycan profiling and intact mass analysis, integration with artificial intelligence driven data interpretation, and adaptation for real time process monitoring in manufacturing. Further automation and miniaturization will continue to enhance accessibility and productivity across research and production settings.

Conclusion

The BioAccord System offers a streamlined, integrated platform for routine peptide mapping that combines easy instrument operation, automated workflows and comprehensive data analysis. This enables reliable characterization of therapeutic protein quality attributes with minimal operator burden and high confidence in regulated laboratories.